Oncology Biomarker Testing Current US Practice Baseline and Emerging Trends
Julia Trosman, Center for Business Models in Healthcare, speaking at Diagnostics & Biomarkers 2015.
Drug Sensitivity and Resistance Testing Platform for Personalized Medicine at the Institute for Molecular Medicine Finland (FIMM)
Jani Saarela, Institute for Molecular Medicine, speaking at Screening Europe 2015
Novel Chip-based Extraction of miRNA
Gregory Dame, University of Freiburg, speaking at Point of Care Diagnostics 2015
Imaging Biomarkers - Future or Reality
Edwin van Beek, University of Edinburgh, speaking at Diagnostics & Biomarkers 2015.
Discovery of Potent and Selective Inhibitors of Monopolar Spindle 1 (MPS1) Kinase
Rob van Montfort, The Institute of Cancer Research, speaking at Discovery Chemistry Congress 2015.
Fit-for-Purpose Biomarker Assay Validation - From Research Tool to Diagnostic Test
Jeff Cummings, Cancer Research UK, speaking at Diagnostics & Biomarkers 2015.
Biomarkers to Predict Aggressive Prostate Cancer
Claire Morgan, Swansea University, speaking at Diagnostics & Biomarkers 2015.
Modifying Cell Lines for Target Discovery and Validation
In this 30-minute seminar, we will discuss the process of genome editing, address factors affecting the design of a genome editing project, and explore the application of modified cell lines for target discovery and validation.
Bacterial Genomic Changes Revealed through Next-generation Sequencing Data Analysis
Lori Snyder, Kingston University, speaking at NSG & Big Data 2014
Detection and Characterization of Viable Circulating Tumor Cells
Catherine Alix-Panabières, University Medical Center of Montpellier, speaking at Advances in Cellular Assays & Cell Culture 2014
|<<|| 1 2 3 4 5 6 7 || >>|
|Showing Results 1 - 10 of 156|